The KAITEKI Institute, Inc. is a global research institute focused on meeting 21st century challenges in energy, the environment, and healthcare.
"Kaiteki," which traditionally means "comfort" or "ease" in Japanese, was chosen for the Institute's name to represent the global quality of life that will be made possible through sustainable technologies and through breakthrough scientific advances in human healthcare.
The Institute will not only fund the highest quality of scientific and engineering research around the world—it will also identify and articulate future societal trends, needs, and challenges, which will be used to set subsequent research targets.
The KAITEKI Institute will propose solutions based on promising research results as new technology platforms within the research arms or businesses of the Mitsubishi Chemical Holdings Group.
The Institute will help make society healthier, more comfortable, and more affluent by supporting long-term R&D and business strategy for the Mitsubishi Chemical Holdings Group, while taking advantage of a global scientific and information network.
Dr. Murayama is President, Representative Director of the Board, and Chairperson of the Advisory Board of The KAITEKI Institute, Inc, from April 2018.
He assumed Managing Executive Officer and CTO of MCC from 2017, Executive Officer of R&D Strategy, MCC, and Executive Officer of R&D Strategy, Mitsubishi Chemical Holdings Corporation (MCHC) from 2016, and Executive Officer of MCC, and President and CEO of Mitsubishi Chemical Group Science and Technology Research Center, Inc. (MCRC) from 2014.
He became Director of Fundamentals R&D Center, MPI, in 2013, Director of Inorganic & Composite Materials Development Center, Mitsubishi Plastics, Inc., (MPI) in 2011, Director of R&D Center, Frontier Carbon Corporation, in 2002, and Director of Hard Disk Development Center, Mizushima Plant, MCC, in 1998. He joined Mitsubishi Chemical Industries Limited (Mitsubishi Chemical Corporation, MCC) in 1986.
Dr. Murayama received a Ph.D. in Engineering from The University of Tokyo in 1986.
Dr. Kobayashi, Director of the Board, is Founder and Former President of The KAITEKI Institute, Inc.
He assumed President and CEO of MCHC as well as President and CEO of MCC from April 2007, Chairperson of MCC from April 2012, and Chairperson of MCHC from February 2015 until June 2021. He also assumed President and CEO of The KAITEKI Institute, Inc. from April 2009, and Chairperson of The Institute from February 2015 until June 2021.
He became CTO and Managing Executive Officer of R&D, MCC, in 2005, and President of Mitsubishi Chemical Media Co., Ltd. in 1996, while presiding over Information Storage Products. He joined Mitsubishi Chemical Industries Limited (Mitsubishi Chemical Corporation, MCC) in 1974.
Dr. Kobayashi received a Master’s degree in Interdisciplinary Science from The University of Tokyo in 1971. On government-sponsored scholarship, he studied Radiation Physics at The Hebrew University of Jerusalem, Israel, in 1972 and at Scuola Normale Superiore in Pisa, Italy, in 1973. He received a Ph.D. in Radiation Physics from The University of Tokyo in 1975.